New polymyxin analogs for the treatment of multidrug-resistant gram-negative nosocomial pathogens

被引：0

作者：

Magee, Thomas ^{[1
]}

Brown, Matthew ^{[1
]}

Starr, Jeremy ^{[1
]}

Miller, Alita ^{[1
]}

Leach, Karen ^{[1
]}

Tomaras, Andrew ^{[1
]}

Dib-Hajj, Fadia ^{[1
]}

Huband, Michael ^{[1
]}

McCurdy, Sandra ^{[1
]}

Irvine, Rebecca ^{[1
]}

Seibel, Scott ^{[1
]}

Luke, David ^{[1
]}

Ackley, David ^{[1
]}

Butler, Andrew ^{[1
]}

Aubrecht, Jiri ^{[1
]}

Granskog, Karl ^{[1
]}

Hardink, Joel ^{[1
]}

Mckim, James ^{[1
]}

Thuy-Trinh Nguyen ^{[1
]}

O'Donnell, John ^{[1
]}

Shen, Yue ^{[1
]}

Wilga, Paul ^{[1
]}

Xu, Jinfeng ^{[2
]}

Zhang, Li ^{[3
]}

Stepan, Antonia ^{[1
]}

Chen, Jinshan ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Groton, CT 06340 USA

[2] Chinese Peptide Co, Hangzhou, Zhejiang, Peoples R China

[3] Wuxi AppTech, Shanghai, Peoples R China

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

397-MEDI

引用

页数：1

共 50 条

[21] In Vitro and In Vivo Effects of the Polymyxin-Vorinostat Combination Therapy Against Multidrug-Resistant Gram-Negative Pathogens
Chen, Haoran
Li, Hongru
Liu, Zhou
Li, Jiabin
[J]. MICROBIAL DRUG RESISTANCE, 2020, 26 (09) : 1108 - 1119
[22] Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
Bian, Xingchen
Liu, Xiaofen
Hu, Fupin
Feng, Meiqing
Chen, Yuancheng
Bergen, Phillip J.
Li, Jian
Li, Xin
Guo, Yan
Zhang, Jing
[J]. FRONTIERS IN PHARMACOLOGY, 2022, 12
[23] Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens
Pybus, Christine A.
Felder-Scott, Christina
Obuekwe, Victor
Greenberg, David E.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (02)
[24] Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' Polymyxins
Paterson, David L.
Bonomo, Robert A.
[J]. POLYMYXIN ANTIBIOTICS: FROM LABORATORY BENCH TO BEDSIDE, 2019, 1145 : 9 - 13
[25] Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia
Ding, Peili
Li, Hangyang
Nan, Yuyu
Liu, Chengwei
Wang, Guobin
Cai, Hongliu
Yu, Wenqiao
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (04)
[26] The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections
Bouza, Emilio
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 : IV38 - IV45
[27] Multidrug-Resistant Gram-Negative Infections What are the Treatment Options?
Giamarellou, Helen
Poulakou, Garyphallia
[J]. DRUGS, 2009, 69 (14) : 1879 - 1901
[28] MRGN: new classification for multidrug-resistant Gram-negative bacteria
Kaase, Martin
[J]. LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2013, 37 (06): : 299 - 304
[29] Valnemulin restores colistin sensitivity against multidrug-resistant gram-negative pathogens
Xu, Chen
Zhang, Yuan
Ma, Lingman
Zhang, Guangfen
Li, Chunli
Zhang, Chenjie
Li, Yunbing
Zeng, Xiangkun
Li, Yuanyuan
Dong, Ning
[J]. COMMUNICATIONS BIOLOGY, 2024, 7 (01)
[30] Antibiotics for multidrug-resistant gram-negative bacteria
Kang, Cheol-In
[J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (08): : 490 - 497

← 1 2 3 4 5 →